Deepbridge Life Sciences News Today

Enterprise Investment Scheme (EIS) investment manager Deepbridge Capital has today (11 January 2022) announced that it has now deployed over £100m of capital via the Deepbridge Technology Growth EIS fund. The Deepbridge Technology Growth EIS was launched in 2013 as one of the first growth-focused technology EIS funds, providing private investors with access to a portfolio of

GBI Magazine spoke to Neciah Dorh, CEO of FluoretiQ, to talk about his Start-Up journey, and how the Deepbridge Life Sciences EIS scheme influenced it.

GBI Magazine spoke to Sameer Kothari, Chief Executive Director of Zilico, to talk about his Start-Up journey, and how the Deepbridge Life Sciences

GBI Magazine spoke to Dr Caroline Barelle, Founder of Elasmogen, to talk about her Start-Up journey, and how the Deepbridge Life Sciences EIS scheme

Deepbridge Capital is a world away from millennial venture capitalists drinking flat whites in East London. For a start, it’s based in unfashionable Cheshire city of Chester. Second, founder and managing partner Ian Warwick is an ex Royal Navy officer who has a no-nonsense northern attitude when it comes to raising money for tech-start-ups. Given his oil rig engineer background, Warwick likes to roll his sleeves up and get under the bonnet of companies he invests in. In that, it’s different...